Tertatolol


Generic Medicine Info
Contraindications
2nd and 3rd degree AV block, sinus bradycardia, uncontrolled heart failure, bronchospasm or asthma, metabolic acidosis, severe peripheral arterial diasease, pheochromocytoma, history of obstructive airways disease.
Special Precautions
1st degree AV block. May mask symptoms of hyperthyroidism and hypoglycaemia. May unmask myasthenia gravis or aggravate psoriasis. May interfere with carbohydrate and lipid metabolism. Patients on long-term treatment should discontinue medication gradually over a period of 1-2 wk as abrupt withdrawal may result in angina, MI, ventricular arrhythmias and death. Pregnancy and lactation.
Adverse Reactions
Bradycardia, hypotension, fatigue, coldness of extremities.
Potentially Fatal: Heart failure, heart block, bronchospasm.
Drug Interactions
Additive hypotensive effect with other antihypertensives, aldesleukin, general anaesthetics. Hypotensive effect antagonised by NSAIDs. Increased risk of bradycardia with digoxin, sotalol and other cardiac depressants.
CIMS Class
ATC Classification
C07AA16 - tertatolol ; Belongs to the class of non-selective beta-blocking agents. Used in the treatment of cardiovascular diseases.
Disclaimer: This information is independently developed by CIMS based on tertatolol from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in